Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) dropped 4.3% during mid-day trading on Monday . The company traded as low as $2.00 and last traded at $1.98, approximately 13,721 shares traded hands during mid-day trading. A decline of 100% from the average daily volume of 7,020,500 shares. The stock had previously closed at $2.07.
The business has a fifty day moving average of $1.59 and a 200-day moving average of $1.77. The company has a debt-to-equity ratio of 0.02, a current ratio of 5.31 and a quick ratio of 5.31.
A hedge fund recently raised its stake in Aethlon Medical stock. Morgan Stanley grew its stake in shares of Aethlon Medical, Inc. (NASDAQ:AEMD) by 9,823.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 69,268 shares of the medical equipment provider’s stock after acquiring an additional 68,570 shares during the period. Morgan Stanley owned about 0.74% of Aethlon Medical worth $106,000 at the end of the most recent reporting period. 3.07% of the stock is currently owned by hedge funds and other institutional investors.
Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.
Further Reading: What is required to own or exchange cryptocurrency?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.